Navigation Links
Alkemists Labs Announces the Expansion of Its New R&D Division
Date:7/16/2013

Costa Mesa, CA (PRWEB) July 16, 2013

Alkemists Laboratories, a leader in natural products analysis and pioneer of cGMP botanical identity testing, announced today it has expanded its service offerings to include a new R&D division focusing on Finished Product Method Development, Verification & Validation.

The new division is a strategic move to improve the service offerings of the company. After a recent expansion of the Alkemists Labs Herbarium (an onsite collection of over 10,000 specimens of ‘herbs of commerce’) in 2012, Alkemists increased its analytical lab space by 50%, which allowed an increased inventory of Waters™ HPLC/UPLCs by 20% and its analytical head count by 30%.

“An R&D division has always been in our strategic plan”, said Élan M Sudberg, CEO of Alkemists Labs. “It’s a joy to see our family business grow to a size that can now effectively execute high end analytical projects for companies making label claims on their finished products. Its one thing to quantify, the gingerols in a raw material of Ginger; the moment that material is combined with another, that same gingerol value may no longer be scientifically valid by the same testing method. This is where our new R&D division steps in to assist our current client base as well as attract and service the quickly growing market of finished products with label claims.”

“In a 483 notice earlier this year, the FDA made clear they are not only hunting for cGMP violations but also companies who market finished products with label claims that have not been verified or validated”, said Sidney Sudberg, CSO of Alkemists Labs. “Between the array of Waters™ HPLC’s with various detectors we now have and the regulatory and multidisciplinary industry expertise of Kelly Reins our Executive Director of Lab Operations & Compliance we are excited to offer pharmaceutical industry quality services to our current and future customers and continue our mission of Providing Peace of Mind in The Natural Products Industry”.

About Alkemists Laboratories:
Founded in 1997, Alkemists Labs is an independent contract testing laboratory of Natural Products and Herbal Medicines. Headquartered in Costa Mesa, CA. Alkemists Labs is a cGMP contract laboratory specializing in routine QC/Compendial testing, method development and validation/verification services, dedicated research services for companies throughout the Food & Beverage, Dietary Supplements and Cosmetic markets. Alkemists Labs offers high through-put HPTLC analysis for Botanical Ingredient Identity Testing of whole herbs and plant extracts with a standard 5 business day turn-around time at no extra charge. In combination with HPLC, Microscopy and our on-site Herbarium, we offer the most reliable technical support and highest quality services so that companies can achieve and maintain cGMP compliance.

Read the full story at http://www.prweb.com/releases/2013/7/prweb10931106.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
2. VaxyGen Assay Services, LLC Announces Launch of Custom Bioassay Services and Operations
3. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
4. ACORN Research, LLC Announces Partnership with AdeptBio, LLC
5. GeoVax Labs, Inc. Announces Nine Month 2011 Financial Results
6. WuXi PharmaTech Announces Third-Quarter 2011 Results
7. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
8. Spherix Announces Third Quarter Financial Results
9. Modern Mobility Aids, Inc. Announces November 30, 2011 Closing of Lumigene Acquisition
10. MedImmune Announces Winners of Its 6th Annual Global Abstract Competition
11. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... 2017 SomaGenics announced the receipt of a ... RealSeq®-SC (Single Cell), expected to be the first commercially ... microRNAs) from single cells using NGS methods. The NIH,s ... accelerate development of approaches to analyze the heterogeneity of ... techniques for measuring levels of mRNAs in individual cells ...
(Date:10/9/2017)...  BioTech Holdings announced today identification and patenting ... stem cell therapy prevents limb loss in animal ... that treatment with ProCell resulted in more than ... to standard bone marrow stem cell administration.  Interestingly, ... of therapeutic effect.  ...
(Date:10/9/2017)... ... October 09, 2017 , ... The Giving Tree Wellness Center ... the needs of consumers who are incorporating medical marijuana into their wellness and ... , As operators of two successful Valley dispensaries, The Giving Tree’s two founders, ...
(Date:10/7/2017)... (PRWEB) , ... October 06, ... ... leader in Hi-C-based genomic technologies, launched its ProxiMeta™ Hi-C metagenome deconvolution product, ... Hi-C kit and accompanying cloud-based bioinformatics software to perform Hi-C metagenome deconvolution ...
Breaking Biology Technology:
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/28/2017)... -- The report "Video Surveillance Market by ... Devices), Software (Video Analytics, VMS), and Service (VSaaS, Installation ... 2022", published by MarketsandMarkets, the market was valued at ... reach USD 75.64 Billion by 2022, at a CAGR ... considered for the study is 2016 and the forecast ...
Breaking Biology News(10 mins):